Open Access

Therapeutic benefit of PKP2 restoration in arrhythmogenic cardiomyopathy

Seminar Presentation

About the speaker

Professor Eva Van Rooij

Hubrecht Institute, Utrecht (Netherlands (The))
5 presentations
0 follower

2 more presentations in this session

Gene therapy approaches in large animal models of cardiomyopathy

Speaker: Professor C. Kupatt (Munich, DE)

Thumbnail

In vivo gene editing for ATTR cardiomyopathy - first in human trial

Speaker: Professor M. Fontana (London, GB)

Thumbnail

Access the full session

Precision medicine: gene editing - RNA therapeutics and the first steps in the clinic

Speakers: Professor E. Van Rooij, Professor C. Kupatt, Professor M. Fontana
Thumbnail

About the event

Image

HFA Winter Research Meeting on Translational Heart Failure 2023

15 March - 18 March 2023

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb